Primary Category:
Treatment Protocols
Disease Category:
Bladder, Genitourinary
Status:
New, Open
Phase II Trial of Intravesical Gemcitabine and MK-3475 (Pembrolizumab) in the Treatment of Patients With BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
NCT#04164082
